Thomas Leggett
2021
In 2021, Thomas Leggett earned a total compensation of $1.9M as Former Chief Financial Officer at Black Diamond Therapeutics.
Compensation breakdown
| Option Awards | $1,411,832 |
|---|---|
| Salary | $381,885 |
| Other | $62,466 |
| Total | $1,856,183 |
Leggett received $1.4M in option awards, accounting for 76% of the total pay in 2021.
Leggett also received $381.9K in salary and $62.5K in other compensation.
Rankings
In 2021, Thomas Leggett's compensation ranked 6,338th out of 12,415 executives tracked by ExecPay. In other words, Leggett earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,338 out of 12,415 | 49th |
Division Manufacturing | 2,697 out of 5,501 | 51st |
Major group Chemicals And Allied Products | 1,184 out of 2,371 | 50th |
Industry group Drugs | 1,054 out of 2,092 | 50th |
Industry Biological Products, Except Diagnostic Substances | 254 out of 449 | 43rd |
Source: SEC filing on April 28, 2022.
Leggett's colleagues
We found three more compensation records of executives who worked with Thomas Leggett at Black Diamond Therapeutics in 2021.